A synergistic generative-ranking framework for tailored design of therapeutic single-domain antibodies
Kong, Y.; Shi, J.; Wu, F.; Zhao, T.; Wang, R.; Zhu, X.; Xu, Q.; Song, Y.; Li, Q.; Wang, Y.; Gao, X.; Yang, Y.; Wu, Y.; Yang, Z.; Yao, J.; Ying, T.
Show abstract
Single-domain antibodies (sdAbs) have emerged as powerful therapeutic agents due to their small size, high stability, and superior tissue penetration. However, unlike conventional monoclonal antibodies (mAbs), sdAbs lack an Fc domain, limiting their functional versatility and manufacturability. To address this challenge, we developed TFDesign-sdAb, a deep learning-based generative-ranking framework that enables rational engineering of sdAbs with tailored functionalities. Our framework integrates a structure-aware diffusion model (IgGM) for large-scale candidate generation and a fine-tuned sorter (A2binder) that evaluates and prioritizes them based on predicted functionality. Unlike traditional CDR-focused approaches, TFDesign-sdAb optimizes both complementarity-determining regions (CDRs) and framework regions (FRs), allowing sdAbs to acquire new functional properties while maintaining antigen specificity. We validated our approach by conferring Protein A binding to human VHs and nanobodies that originally lacked this feature, achieving high expression rates, strong binding affinities, and successful purification via industry-standard Protein A affinity chromatography. High-resolution structural characterization (1.49 [A] and 2.0 [A]) of the redesigned sdAb-Protein A complexes revealed conserved FR-mediated binding motifs that recapitulate natural Fc-Protein A interactions, validating the accuracy of our model. Furthermore, our pipeline streamlined the antibody engineering process, achieving a 100% success rate in generating Protein A-binding sdAbs while maintaining their original antigen-binding affinity. This work demonstrates the power of AI-driven design in overcoming long-standing limitations in antibody engineering and presents a scalable, generalizable solution for enhancing sdAb functionality.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- High-accuracy protein complex structure modeling based on sequence-derived structure complementarity 96%
- Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 95%
- Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain 95%
Similar papers in this journal
- AlphaBind, a Domain-Specific Model to Predict and Optimize Antibody-Antigen Binding Affinity 96%
- Tuning antibody stability and function by rational designs of framework mutations 95%
- Towards generalizable prediction of antibody thermostability using machine learning on sequence and structure features 95%
Similar papers in this journal
- Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling 95%
- Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability 95%
- On-rate modulation of cadherin interactions by chemical fragments 94%
Similar papers in this journal
- Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations 96%
- What Strengthens Protein-Protein Interactions: Analysis and Applications of Residue Correlation Networks 94%
- Biomolecular recognition of the glycan neoantigen CA19-9 by distinct antibodies 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.